Skip to content

Craving & Decision-Making

Decision Neuroscience of Craving

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06440577
Enrollment
160
Registered
2024-06-04
Start date
2024-06-18
Completion date
2027-12-01
Last updated
2026-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decision Making

Keywords

Craving, Decision Making, Opioid Use Disorder, Dietary Choice

Brief summary

Craving is the strong desire for something, such as for substances in drug addiction and food or other activities in everyday life. Recent work suggests craving can influence how people make decisions and assign value to choice options available to them, yet the neural mechanisms underlying these interactions between craving and valuation remain unknown. To address this, this study uses cognitive decision-making tasks that measure how much individuals will pay (from a study endowment) to have everyday consumer items or snack foods when they crave something specific (opioids or a specific snack, respectively). First, the study will identify the neural mechanisms for how drug craving (craving for opioids) interacts with valuation for consumer items that have associations with drug use or not in people receiving treatment for opioid use disorder (OUD). This will be evaluated in the activity patterns and interactions among brain regions involved in craving and value assignment during decision-making. Then, the study will examine for parallel mechanisms for how food craving (craving for a specific snack) interacts with valuation for snack food items that have similar features to the craved snack or not in people receiving treatment for OUD and non-psychiatric community control participants.

Interventions

BEHAVIORALAudio-visual stimuli (Neutral-Relaxing)

Audio instruction for participant to allow themselves to experience their feelings followed by 3-min passive viewing of images of neutral everyday objects (e.g., tools, dirt) and their use (construction, gardening).

BEHAVIORALAudio-visual stimuli (Drug)

Audio instruction for participant to allow themselves to experience their feelings followed by 3-min passive viewing of images of drug paraphernalia (e.g., syringe, tourniquet, heroin) and preparation.

BEHAVIORALAudio-visual stimuli (Non-Food)

Audio instruction for participant to focus their attention on the experimenter followed by 3-min audio-guided viewing of the experimenter opening/unwrapping an everyday object (e.g., box of crayons) and taking out its contents.

BEHAVIORALAudio-visual stimuli (Food)

Audio instruction for participant to focus their attention on the experimenter followed by 3-min audio-guided viewing of the experimenter opening/unwrapping a snack (e.g., chocolate bar, bag of chips) and taking out its contents.

Sponsors

Rutgers, The State University of New Jersey
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Men and women with OUD receiving medications for OUD treatment will complete both the Consumer Items Willingness-to-Pay Task and Snack Foods Willingness-to-Pay Task at two separate task sessions. Non-psychiatric community control participants will complete the Snack Foods Willingness-to-Pay Task.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years of age * Willingness to follow study requirements, as evidenced by an ability to provide written informed consent and read, understand, and complete the study procedures * Minimum of 6th grade reading level Additional inclusion criteria for participants with OUD: * Primary diagnosis of OUD encompassing heroin and/or painkiller use * Receiving medications for OUD treatment on an outpatient basis * At least 12-month history of opioid use

Exclusion criteria

* Unable to speak or read English * Active psychosis or mania * Current or past schizophrenia diagnosis * History of intellectual disability or developmental or neurological disorder, seizures or epilepsy, or loss consciousness lasting more than 30 minutes * Severe medical conditions requiring hospitalization or that, in the opinion of the study staff could compromise study participation * MRI contraindications (claustrophobia, nonremovable piercings, certain metal in the body etc.) or pregnancy Additional

Design outcomes

Primary

MeasureTime frameDescription
Willingness-to-payduring the taskThe amount that a participant would be willing to pay for different available choice options. This is measured during the decision-making tasks in which participants are shown images of consumer items or snack foods and report how much they would be willing to pay to have the different items in that moment.
fMRI-BOLD activity measured during willingness-to-pay decisionsduring the taskFunctional MRI data will be analyzed to measure changes in blood-oxygen-level-dependent (BOLD) signal in specific regions of interest based on prior research (ventral striatum, ventromedial prefrontal cortex, amygdala, and insula) as participants make willingness-to-pay decisions during each task.

Countries

United States

Contacts

CONTACTAnna Konova, PhD
anna.konova@rutgers.edu732-235-4335
PRINCIPAL_INVESTIGATORAnna Konova, PhD

Rutgers, The State University of New Jersey

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 5, 2026